| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.7M | +208.3% |
| Cost of Revenue | $2.4M | +356.6% |
| Gross Profit | $3.2M | +147.6% |
| R&D Expense | $161K | +522.8% |
| SG&A Expense | $2.2M | +92.5% |
| Operating Income | $719K | +726.5% |
| Income Tax | $77K | — |
| Net Income | $642K | +638.0% |
| EPS (Basic) | $0.06 | — |
| EPS (Diluted) | $0.06 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $662K | -0.1% |
| Accounts Receivable | $399K | +298.1% |
| Inventory | $336K | +476.7% |
| Current Assets | $1.6M | +83.9% |
| Total Assets | $1.7M | +95.4% |
| Total Liabilities | $230K | +496.3% |
| Stockholders' Equity | $1.5M | +76.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $172K | +642.5% |
| Investing Cash Flow | -$57K | -118.3% |
| Financing Cash Flow | -$116K | -117.9% |